Skip to main content
Caplight Logo









EmGenisys

EmGenisys

Private
TexasHealthcare & Life Scienceshttps://www.emgenisys.co/

Last Round

Seed Round

Mar 24, 2026

Total Funding Raised

$2.1M

Company Overview

EmGenisys is an ag-tech company that provides a SaaS platform using artificial intelligence to analyze embryo health and improve pregnancy outcomes for assisted reproductive techniques in livestock.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Computer Vision, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

embryo health assessmentagtechlivestock IVFembryo viabilitycomputer visionvertical SaaSembryo sexingmedical AImorphokinetic analysisAI embryo gradingsmart farmingveterinary softwareprecision livestockIVF techembryo screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EmGenisys Comparables

Compare EmGenisys with similar companies based on industry and business-model similarity.

EmGenisys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Verility Inc.
74%
Vytelle
66%
IMV Technologies
60%

EmGenisys Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 24, 2026
SeedJul 23, 2025
GrantSep 26, 2024
GrantAug 27, 2024
GrantJan 9, 2023
Accelerator
Sep 23, 2022

Key People

Founding team and executive leadership

Cara Wessels Wells

Founder And CEO

Founding Team

Tim Boyer

Chief Technology Officer

Executive Team

Ashby Green

Investor, Fractional CFO

Executive Team

EmGenisys Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2025

    $1.5M raised in Seed round.

  • Sep 26, 2024

    $250K grant received from BioTools Innovator.

EmGenisys Filings

Explore SEC and related filing metadata, where available.

EmGenisys filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EmGenisys's valuation, stock price, and market status.

Is EmGenisys a public or private company?

EmGenisys is a private company.

What is the current stock price of EmGenisys?

EmGenisys is a private company with no public stock price. No recent secondary market data is available.

How much is EmGenisys worth (valuation)?

Valuation information for EmGenisys is not publicly available.

Can I buy EmGenisys stock?

EmGenisys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EmGenisys's last funding round?

EmGenisys's most recent funding round was Seed Round on March 24, 2026.

Who are the main investors in EmGenisys?

Key investors in EmGenisys include Grit Road Partners.

Will EmGenisys IPO soon?

No public IPO plans have been announced for EmGenisys.

How can I track EmGenisys secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EmGenisys's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTexas
Employee Range6
Year Founded2020
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?